• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

AgeChem Venture Fund

edit

The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting age-related diseases. Principally, AgeChem wishes to build a portfolio of Companies developing novel therapeutics to treat metabolic disorders (e.g. diabetes, obesity), cardiovascular diseases, cancers, diseases of the central nervous system (e.g. Alzheimer, Parkinson, insomnia), inflammatory diseases (e.g. rheumatoid arthritis, psoriasis), ophthalmic diseases and numerous other age-related diseases.

Recent Milestones

edit

• 
  AgeChem Venture Fund invested in Alethia BioTherapeutics. (11/2/12)
  Posted 11/1/12 at 9:17pm via yahoo.com
• 
  AgeChem Venture Fund invested in Aerpio Therapeutics. (8/30/12)
  Posted 8/30/12 at 6:31pm via finsmes.com
• 
  AgeChem Venture Fund invested in Akebia Therapeutics. (1/9/12)
  Posted 1/9/12 at 7:18pm via finsmes.com
• 
  AgeChem Venture Fund invested in Sorbent Therapeutics. (6/30/11)
  Posted 6/30/11 at 4:03am via msn.com
• 
  AgeChem Venture Fund invested in Akebia Therapeutics. (4/26/11)
  Posted 4/26/11 at 5:12pm via akebia.com
• 
  AgeChem Venture Fund invested in Conatus Pharmaceuticals. (2/11/11)
  Posted 2/12/11 at 3:52am via pharmalive.com
• 
  AgeChem Venture Fund invested in Sorbent Therapeutics. (9/13/10)
  Posted 9/13/10 at 6:04pm via dowjones.com
• 
  AgeChem Venture Fund invested in Alethia BioTherapeutics. (9/7/10)
  Posted 9/8/10 at 5:39pm via dowjones.com
• 
  AgeChem Venture Fund invested in Altair Therapeutics. (2/2/10)
  Posted 11/11/09 at 4:18pm via onbiovc.com
• 
  AgeChem Venture Fund invested in Sonexa Therapeutics. (1/31/08)
  Posted 12/20/09 at 11:06pm via biospace.com

Investments

Videos

Sources

1. Alethia Biotherapeutics Closes a $4.7 Million Financing to Advance its Bone Antiresorptive Program (finance.yahoo.com) [edit]
2. Aerpio Therapeutics Closes $27M Series A Financing (finsmes.com) [edit]
3. Akebia Therapeutics Raises $4.1M in Series B Financing (finsmes.com) [edit]
4. Sorbent Therapeutics Completes $36 Million Series B Financing for Net of $53 Million (money.msn.com) [edit]
5. AKEBIA COMPLETES $22M SERIES B FINANCING (akebia.com) [edit]
6. Conatus Pharmaceuticals Completes $20 Million Series B Private Placement Financing (pharmalive.com) [edit]
7. Sorbent Raises $21.8M Series B, Names New CEO (fis.dowjones.com) [edit]
8. Alethia Biotherapeutics Brings Home $9.2M Series A (fis.dowjones.com) [edit]
9. Altair Therapeutics, Inc.: Series B $17M (onbiovc.com) [edit]
10. Sonexa Therapeutics, Inc. Raises $30 Million in Series A Financing to Focus on Alzheimer's Treatments (biospace.com) [edit]